Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma
PHASE1
This phase I trial studies the side effects and best dose of genetically mo...
Analysis of Graft Function Following Autologous Islet Transplantation
N/A
Analyze inflammatory markers and islet graft function through blood samples...
Status
Recruiting
Location
Baylor University Medical Center - Sammons Outpatient Cancer Center
Start Date
2010-06-03
Trial ID
NCT03097185
Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation
EARLY_PHASE1
The purpose of this study is to determine the efficacy of aprepitant in pre...